The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
Menopause and renal disease
Diabesity Working Group
Speaker
Esteban Porrini, Spain
Panellists
Anette Tønnes Pedersen, Denmark
Ana Rodríguez, Spain
Moderator
Morten Buus Jørgensen, Denmark
The webcast will be available soon.